Nortriptyline Treatment of Post-Stroke Depression

Completed

Phase N/A Results

Summary of Purpose

To assess the efficacy of nortriptyline in the treatment of poststroke depression.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institutes for Health

Trial Design

Double-blind, randomized, placebo-controlled trial of 34 patients.

Contacts

Not available